PATIENT Act of 2023

Summary

Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023 This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. Specifically, the bill provides statutory authority for the requirement that hospitals publish an annual list of shoppable services they provide, including specified pricing information. Beginning in 2025, a hospital may not use an internet-based price estimator tool to meet the publication requirement for shoppable services. The bill also modifies the health insurance plan disclosure requirements to include the rates for certain in-network services and prescription drug payment information. The bill further requires providers of diagnostic laboratory tests under Medicare to publish online certain price information. Medicare Advantage (MA) organizations must report information about payments made to providers in which the MA organization has an ownership interest. Medicare prescription drug plan sponsors must report certain price information for covered drugs. Additionally, the bill requires health insurance plan issuers (or the PBM providing services on behalf of the plan) to report to the plan sponsor specified information about prescription drugs dispensed under the plan. This includes rebates, fees, alternative discounts, or other remuneration the plan receives from drug manufacturers. Finally, the bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 22 May 2023

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 22 May 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 22 May 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 24 May 2023

   Vote

   Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.

   Source: Committee

5. 24 May 2023

   Committee

   Committee Consideration and Mark-up Session Held.

   Source: Committee

6. 17 December 2024

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 22 May 2023 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 22 May 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 22 May 2023

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 22 May 2023

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. McMorris Rodgers, Cathy [R-WA-5] · R · Sponsor
• Rep. Pallone, Frank [D-NJ-6] · D · Sponsor
• Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Cosponsor
• Rep. Bilirakis, Gus M. [R-FL-12] · R · Cosponsor
• Rep. Bucshon, Larry [R-IN-8] · R · Cosponsor
• Rep. Guthrie, Brett [R-KY-2] · R · Cosponsor
• Rep. Buchanan, Vern [R-FL-16] · R · Cosponsor
• Rep. Balderson, Troy [R-OH-12] · R · Cosponsor
• Rep. Joyce, John [R-PA-13] · R · Cosponsor
• Rep. Allen, Rick W. [R-GA-12] · R · Cosponsor
• Rep. Johnson, Bill [R-OH-6] · R · Cosponsor
• Rep. Dunn, Neal P. [R-FL-2] · R · Cosponsor
• Rep. Hudson, Richard [R-NC-8] · R · Cosponsor
• Rep. Cammack, Kat [R-FL-3] · R · Cosponsor
• Rep. Bice, Stephanie I. [R-OK-5] · R · Cosponsor
• Rep. Barragán, Nanette Diaz [D-CA-44] · D · Cosponsor
• Rep. Kuster, Ann M. [D-NH-2] · D · Cosponsor
• Rep. Sarbanes, John P. [D-MD-3] · D · Cosponsor
• Rep. Craig, Angie [D-MN-2] · D · Cosponsor
• Rep. Harshbarger, Diana [R-TN-1] · R · Cosponsor
• Rep. Latta, Robert E. [R-OH-5] · R · Cosponsor
• Rep. Obernolte, Jay [R-CA-23] · R · Cosponsor
• Rep. Higgins, Clay [R-LA-3] · R · Cosponsor
• Rep. Duncan, Jeff [R-SC-3] · R · Cosponsor
• Jake LaTurner · R · Cosponsor
• Rep. Peters, Scott H. [D-CA-50] · D · Cosponsor
• Rep. Schakowsky, Janice D. [D-IL-9] · D · Cosponsor
• Rep. Miller-Meeks, Mariannette [R-IA-1] · R · Cosponsor
• Rep. Lesko, Debbie [R-AZ-8] · R · Cosponsor
• Rep. Crenshaw, Dan [R-TX-2] · R · Cosponsor
• Sen. Curtis, John R. [R-UT] · R · Cosponsor
• Rep. Smith, Christopher H. [R-NJ-4] · R · Cosponsor
• Rep. James, John [R-MI-10] · R · Cosponsor
• Rep. Moore, Barry [R-AL-1] · R · Cosponsor
• Rep. Stefanik, Elise M. [R-NY-21] · R · Cosponsor
• Rep. Cherfilus-McCormick, Sheila [D-FL-20] · D · Cosponsor
• Rep. Moolenaar, John R. [R-MI-2] · R · Cosponsor
• Rep. De La Cruz, Monica [R-TX-15] · R · Cosponsor
• Rep. Matsui, Doris O. [D-CA-7] · D · Cosponsor
• Rep. Van Duyne, Beth [R-TX-24] · R · Cosponsor
• Rep. Fallon, Pat [R-TX-4] · R · Cosponsor
• Rep. Babin, Brian [R-TX-36] · R · Cosponsor
• Rep. Bergman, Jack [R-MI-1] · R · Cosponsor
• Yadira Caraveo · D · Cosponsor
• Rep. Mills, Cory [R-FL-7] · R · Cosponsor
• Rep. Lee, Susie [D-NV-3] · D · Cosponsor
• Rep. Westerman, Bruce [R-AR-4] · R · Cosponsor
• Sen. Schiff, Adam B. [D-CA] · D · Cosponsor

Showing 48 of 92 sponsors and actors.

Related records

• related to → Transparent PRICE Act
• related to → Drug Price Transparency in Medicaid Act of 2023
• related to → Supporting Safety Net Hospitals Act
• related to → Pharmacy Benefits Manager Accountability Act
• related to → Transparent PRICE Act
• related to → To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department.
• related to → Diagnostic Lab Testing Transparency Act
• related to → To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
• related to ← To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Showing 9 of 12 related records.